Diagnosis
Global partnership to improve diagnostic accuracy of breast cancer
A new partnership aims to advance AI-enabled digital pathology for end-to-end breast tumour profiling
PathPresenter, a digital pathology platform and 4D Path, a Boston company producing computer-aided cancer diagnostic products, are announcing a global partnership to distribute 4D Q-plasia OncoReader Breast within the new clinical workflow platform, ClinPx.
The 4D Q-plasia OncoReader Breast uses digitised pathology slides of breast cancer tissue to diagnose disease with improved accuracy, effectively acting as an aid for clinical histopathology experts.
“We believe that the integration of these two technologies will redefine how AI can be adopted by everyday pathologists,” says Rajendra Singh, M.D., founder of PathPresenter.
The primary purpose of integrating 4D’s proprietary algorithms within ClinPx is to potentially improve the throughput, reliability and quality of consultations provided by physicians. Additionally, users from pharmaceutical organisations could also benefit from the enablement of the standardised central pathology review of certain biomarkers within the context of clinical trials leveraging the ClinPx platform.
“This unique partnership is very much needed to make the most of the increasing investment in digital pathology,” says Tathagata Dasgupta, founder and president of 4D Path.
“While PathPresenter offers a software platform made by pathologists to serve pathologists in their digital workflow, it will have at its heart the 4D Path-driven end-to-end tumour profiling white-box solution that can produce synoptic reports to potentially assist clinical reporting.”
To advance the adoption of digital pathology worldwide, 4D Path and PathPresenter have also created educational content to teach current and future pathologists about how evaluation of breast cancer features prior to downstream genomic and molecular testing can potentially improve patient care.
In the UK, 4D Path has an existing partnership with the University of Leeds, after previously completing three breast cancer clinical studies with the university.
Insight
AI model predicts five-year breast cancer risk
A new AI model can predict a person’s risk of developing breast cancer up to five years in advance by analysing mammograms.
The technology could make screening more effective by identifying women who need additional imaging.
In one study, women the algorithm flagged as high risk were four times more likely to develop breast cancer than those with a low AI score.
The Clairity Consortium, an international association of 46 research institutions in North and South America and Germany, developed the model, Clairity Breast, trained on more than 420,000 mammograms.
Christiane Kuhl, director of the department of diagnostic and interventional radiology at RWTH Aachen University Hospital, said: “With this newly-developed AI model, we can predict with much greater precision that a woman will develop breast cancer in the next five years, on the basis of mammograms that are normal and show no signs of breast cancer.”
Unlike traditional risk models, the AI does not need family history, genetics or lifestyle data. It calculates risk from mammograms alone and classifies women into risk categories.
The model assesses not only the amount of glandular tissue but also its texture and arrangement, another breast cancer risk factor.
Kuhl said current “one-size-fits-all” screening is outdated.
“The AI model can decide within seconds whether a woman needs an MRI for early detection or not,” she said.
MRI uses magnetic fields and radio waves to create detailed images but is more expensive than mammography.
Kuhl advocated a two-step approach: “First, mammography for early detection; then an AI analysis to determine the risk of disease over the next five years.”
Insight
Study finds gender gap in knee injuries
One of the largest MRI studies comparing knee injuries by sex has found age-related differences in patterns.
The findings could be used to improve risk assessment and develop early intervention strategies.
Researchers analysed 13,549 consecutive routine knee MRI exams performed between 2019 and 2024 at four outpatient radiology facilities affiliated with Johns Hopkins Hospital in the US. All patients reported knee pain as their primary complaint.
The team extracted data on tears and injuries to key structures including the menisci, C-shaped cartilage that cushions the joint, and the anterior cruciate ligament (ACL), a major ligament that stabilises the knee during twisting, jumping and sudden direction changes.
Analysis revealed that ACL tears, both alone and combined with meniscal tears, were observed more frequently in men than women.
Ali Ghasemi, postdoctoral research fellow at Johns Hopkins, said: “We saw more ACL tears in men especially in the 20- to 40-year-old age group, which is contrary to what’s been reported in the literature.
“Prior studies focused on sports-related injuries have shown that young women athletes have increased rates of and a greater risk for ACL tears.
“However, our results show a significantly higher prevalence of ACL injuries in male patients across all age groups.”
Men had a greater number of injuries overall.
However, the researchers found that meniscal tears and injuries to the medial collateral ligament (MCL), which stabilises the inner knee, occurred more frequently in men under 40 but were more common in older women.
Ghasemi said: “In younger patients, meniscal and MCL tears were more commonly seen in men, while in older patients, women had more of these types of tears than men, which was unexpected.”
The findings suggest older women are more prone to injuries that lead to joint degeneration over time.
Study co-author Jenifer Pitman, assistant professor of radiology at Johns Hopkins Medical Institute, theorised the discrepancy between their findings and previous research may be due to broadening the focus beyond sports-related injuries.
She said: “The pre-established notion that ACL tears are more common in younger women may not be the case 100 per cent of the time.
“Radiologists can also expect to see more frequent meniscal pathology and arthritis in older women.”
Pitman advised that women over 40 should pay attention to joint health and consider strength training to protect their knees.
pain conditions
Global disparities found in endometriosis care guidance
An analysis has found significant geographical gaps in endometriosis care guidance worldwide.
The condition affects an estimated 190 million women globally, with research indicating a gap of up to 12 years between symptom onset and diagnosis.
It has also been identified as one of the main causes of a 75 million disability-adjusted life-year gender health gap, a measure that quantifies years lost to illness, disability or premature death.
The scoping review, a broad mapping of available guidance, assessed availability across 194 World Health Organization-defined countries through bibliographic searches and grey literature reviews.
After screening, researchers identified 143 unique sources for care guidance across 141 countries, so 27 per cent of WHO-defined countries had no identifiable guidance related to care.
Only New Zealand and Peru had both professional society and government guidance, placing them at the highest level of the researchers’ ranking.
In contrast, news media was the highest available source of guidance for 12 per cent of countries.
Regional differences were stark.
All European countries had some level of care guidance, while 32 African countries had none, despite 21 of these having a specific society or advocacy group.
The study investigators wrote: “Many people who are affected by endometriosis might benefit from centres of expertise with multidisciplinary specialist care.
“However, there are many potential socioeconomic, geographical, and clinical barriers to reaching these specialist services.”
Meanwhile, surgical technology is being used to improve diagnosis.
Megan Wasson, chair of gynaecology at Mayo Clinic, noted that visual recognition and training are vital, as the condition often varies in appearance.
Advances in laparoscopy (keyhole surgery) and robotic surgery have improved magnification, helping clinicians identify atypical presentations.
Wasson said: “Being able to really zoom in on these lesions and see the difference in normal versus abnormal peritoneum is incredibly helpful.”
-
Features3 days agoCannabis compounds kill ovarian cancer without harming healthy cells, research finds
-
Opinion2 weeks agoFemtech in 2025: A year of acceleration, and what data signals for 2026
-
News3 weeks agoInnovate UK relaunches £4.5m women founders programme
-
News3 weeks agoDoctors push back on ‘data-free’ ruling on menopause hormone therapy
-
Insight7 days agoMeta removes dozens of abortion advice and queer advocacy accounts
-
Wellness4 weeks agoWhy women’s health tech is crucial in bridging the gender health gap
-
Insight1 week agoSperm donor with cancer-causing gene fathered nearly 200 children across Europe
-
Fertility2 weeks agoRound up: First wearable detects symptoms of perimenopause, and more






